Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment

Status:

WITHDRAWN

Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment

Lead Sponsor:

National Institute of Medical Sciences and Nutrition, Salvador Zubiran

Conditions:

Mild Cognitive Impairment

Eligibility:

All Genders

60+ years

Phase:

Brief Summary

Supervised nonpharmacologic therapy improve cognitive function in patients with Mild Cognitive Impairment

Eligibility Criteria

Inclusion

Patients 60 years and older with Mild Cognitive Impairment according to Petersen Criteria
Phone number available

Exclusion

Untreated depression
Evidence of a reversible cause of cognitive decline
Dementia of any type and stage
Severe sensory deficit unresolved
Metastatic cancer
Hemoglobin level \< 8g/dL
Chronic Obstructive Pulmonary Disease Gold stage 3 or 4
Congestive Heart Failure decompensated, unstable angina o Functional Class IV according to New York Heart Association
Participation in another protocol that prevents its participation in this research
Chronic use of benzodiazepines, tricyclic antidepressants
Patients whose place of residence can not attend the sessions

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01819623

Last Update

April 22 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)